HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Raffaele Addeo Selected Research

fotemustine (Muphoran)

1/2019Biweekly fotemustine schedule for recurrent glioblastoma in the elderly: activity and toxicity assessment of a multicenter study.
9/2013Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC.
5/2011A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma.
10/2009Fotemustine and recurrent glioblastoma: possible new opportunities for an old drug.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Raffaele Addeo Research Topics

Disease

28Neoplasms (Cancer)
03/2022 - 01/2007
12Breast Neoplasms (Breast Cancer)
10/2019 - 08/2004
10Colorectal Neoplasms (Colorectal Cancer)
04/2022 - 08/2009
9Brain Neoplasms (Brain Tumor)
01/2021 - 01/2006
9Neoplasm Metastasis (Metastasis)
01/2021 - 01/2007
8Hepatocellular Carcinoma (Hepatoma)
07/2016 - 03/2009
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2020 - 11/2008
5Carcinoma (Carcinomatosis)
05/2021 - 11/2007
5Melanoma (Melanoma, Malignant)
02/2020 - 11/2008
4Glioblastoma (Glioblastoma Multiforme)
01/2019 - 10/2009
3Disease Progression
01/2021 - 01/2009
3Head and Neck Neoplasms (Head and Neck Cancer)
01/2019 - 01/2016
3Pain (Aches)
05/2010 - 02/2008
2Lung Neoplasms (Lung Cancer)
01/2021 - 01/2017
2Exanthema (Rash)
11/2016 - 01/2010
2Glioma (Gliomas)
07/2014 - 11/2008
2Bone Diseases (Bone Disease)
01/2014 - 01/2010
2Anemia
01/2014 - 10/2009
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2013 - 05/2004
1Stomach Neoplasms (Stomach Cancer)
04/2022
1Microsatellite Instability
04/2022
1Inflammation (Inflammations)
03/2022
1Laryngeal Neoplasms (Laryngeal Cancer)
03/2022
1Circulating Neoplastic Cells
03/2022
1Neuroendocrine Carcinoma
05/2021
1Diarrhea
11/2019
1Weight Loss (Weight Reduction)
01/2019
1Squamous Cell Carcinoma of Head and Neck
01/2018
1Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2018
1Skin Diseases (Skin Disease)
11/2016
1Fibrosis (Cirrhosis)
07/2016
1Liver Diseases (Liver Disease)
07/2016
1Prostatic Neoplasms (Prostate Cancer)
10/2014
1Hematologic Neoplasms (Hematological Malignancy)
10/2014
1Second Primary Neoplasms (Neoplasms, Second)
07/2014
1Leukemia
10/2013
1medullary Thyroid cancer
10/2013

Drug/Important Bio-Agent (IBA)

8Cetuximab (Erbitux)FDA Link
08/2021 - 08/2009
7Temozolomide (Temodar)FDA LinkGeneric
01/2021 - 01/2006
7Sorafenib (BAY 43-9006)FDA Link
07/2016 - 01/2010
7Pharmaceutical PreparationsIBA
07/2016 - 11/2007
6Monoclonal AntibodiesIBA
08/2021 - 04/2010
4fotemustine (Muphoran)IBA
01/2019 - 10/2009
4Vinorelbine (Navelbine)FDA LinkGeneric
02/2016 - 07/2008
4Bevacizumab (Avastin)FDA Link
09/2014 - 05/2010
4Oxaliplatin (Eloxatin)FDA LinkGeneric
05/2013 - 07/2004
4Zoledronic Acid (Zometa)FDA Link
05/2010 - 02/2008
3Biomarkers (Surrogate Marker)IBA
04/2022 - 01/2016
3Biological ProductsIBA
03/2022 - 03/2009
3Cisplatin (Platino)FDA LinkGeneric
01/2019 - 05/2010
3Phosphotransferases (Kinase)IBA
07/2014 - 01/2010
3Hemoglobins (Hemoglobin)IBA
01/2014 - 04/2009
3Diphosphonates (Bisphosphonates)IBA
01/2014 - 02/2008
2Immune Checkpoint InhibitorsIBA
04/2022 - 01/2017
2ErbB Receptors (EGF Receptor)IBA
08/2021 - 11/2016
2MicroRNAs (MicroRNA)IBA
05/2021 - 03/2015
2Tyrosine Kinase InhibitorsIBA
11/2016 - 02/2011
2Gefitinib (Iressa)FDA Link
11/2016 - 07/2014
2Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2016 - 07/2014
2Panitumumab (Vectibix)FDA Link
11/2016 - 04/2010
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2013 - 05/2010
2thiamine triphosphorate (TTP)IBA
01/2013 - 01/2010
2Endothelial Growth FactorsIBA
07/2011 - 05/2010
2Etoposide (VP 16)FDA LinkGeneric
07/2011 - 05/2010
2Antineoplastic Agents (Antineoplastics)IBA
07/2011 - 11/2008
2NF-kappa B (NF-kB)IBA
04/2011 - 08/2009
2Irinotecan (Camptosar)FDA LinkGeneric
04/2010 - 08/2009
2HematinicsIBA
10/2009 - 04/2009
2Doxorubicin (Adriamycin)FDA LinkGeneric
07/2008 - 03/2005
1Proteins (Proteins, Gene)FDA Link
04/2022
1DNA (Deoxyribonucleic Acid)IBA
03/2022
1Silybin (Lagosa)IBA
01/2021
1trifluridine tipiracil drug combinationIBA
01/2020
1SuspensionsIBA
11/2019
1PlatinumIBA
01/2019
1human ERBB2 proteinIBA
09/2018
1exemestane (Aromasin)FDA Link
09/2018
1EverolimusFDA Link
09/2018
1Hormones (Hormone)IBA
09/2018
1Aromatase InhibitorsIBA
09/2018
1regorafenibIBA
02/2017
1Interleukin-8 (Interleukin 8)IBA
11/2016
1LigandsIBA
11/2016
1DapsoneFDA Link
11/2016
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2016
1Drug CombinationsIBA
07/2016
1pembrolizumabIBA
01/2016
1IpilimumabIBA
10/2014
1sipuleucel-T (APC8015)FDA Link
10/2014
1Methotrexate (Mexate)FDA LinkGeneric
10/2014
1ErythropoietinFDA Link
01/2014

Therapy/Procedure

24Therapeutics
05/2021 - 05/2004
21Drug Therapy (Chemotherapy)
08/2021 - 07/2004
6Radiotherapy
01/2021 - 01/2007
2Immunotherapy
01/2019 - 10/2014
2Blood Transfusion (Blood Transfusions)
10/2009 - 04/2009
1Combined Modality Therapy
01/2021
1Neoadjuvant Therapy
10/2019
1Contraindications
01/2019
1Chemoradiotherapy
01/2018